'Living drugs' target CD70 in advanced renal tumors

Wagner, Kilian and Siska, Peter J. (2024) 'Living drugs' target CD70 in advanced renal tumors. TRENDS IN PHARMACOLOGICAL SCIENCES, 45 (9). pp. 757-759. ISSN 0165-6147, 1873-3735

Full text not available from this repository. (Request a copy)

Abstract

Cellular therapies against solid tumors face three major barriers: low persistence, insufficient specificity, and high costs. In a recent study, Pal et al. tackle these challenges in kidney cancer by using novel, 'persistence-tuned' allogeneic chimeric antigen receptor (CAR) T cells directed against a stable antigen.

Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Dr. Gernot Deinzer
Date Deposited: 29 Oct 2025 12:12
Last Modified: 29 Oct 2025 12:12
URI: https://pred.uni-regensburg.de/id/eprint/63768

Actions (login required)

View Item View Item